Roche bags 'breakthrough' anti-fibrosis drug in $1.4B biotech buyout deal
Roche is snapping up a “breakthrough” anti-fibrotic drug in a $1.4 billion buyout.
The pharma giant announced Friday that it is acquiring Promedior, primarily to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
